Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Highfield, Innovent, Junshi, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Delta-Fly, GPN Vaccines, Immutep, Jiangsu Recbio, Gannex Pharma, Belief Biomed, Innovent, Sciwind.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Caliway, Carina Biotech, Clairy, CSL, Daiichi, Highfield, Innocare, Lynx, Neuren, Shapiron, Sumitomo, Yoltech.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 1st Biotherapeutics, Alebund, Clover, Dizal, Hutchmed Imagion, Qilu.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Bionomics, Innovent, Merck, Neuren, Qulu, Ribomic, Technoderma.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Chengdu, Innovent, Kazia, Micurx.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adlai Nortye Biopharma, Aribio, Brii Biosciences, Certa Therapeutics, Neuren Pharmaceuticals, SCG Cell Therapy, Visen Pharmaceuticals.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko Therapeutics, Akeso, Allgenesis Biotherapeutics, Alterity Therapeutics, Bioray Pharmaceutical, Gannex Pharma, Immutep, Immvira Group, Innovent Biologics, JCR Pharmaceuticals, Neurocrine Biosciences, Otsuka Pharmaceutical, Pharmabcine, Qilu Pharmaceutical, Recce Pharmaceuticals, Senhwa Biosciences, Takeda Pharmaceutical.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Biogen, Biosyngen Bridge, Calliditas, F2G, Genexine, Henlius, Highfield, Iksuda, Innocare, OLife Molecular, tsuka, Recce, Samsung Bioepis, SN Bioscience, Sumitomo.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Biogen, Biosyngen Bridge, Calliditas, F2G, Genexine, Henlius, Highfield, Iksuda, Innocare, OLife Molecular, tsuka, Recce, Samsung Bioepis, SN Bioscience, Sumitomo.